Phase I Clinical Study For Covaxin Shows Robust Immune Response : Bharat Biotech

Like
Like Love Haha Wow Sad Angry

Covaxin Phase I Trial Report Shows Robust Immunological Response The early results of Phase I studies of Covaxin, the COVID-19 vaccine, indigenously produced by Bharat Biotech jointly with ICMR, proved that it was effective in tolerating and with no adverse or serious effects in all dose types. The immunization shots triggered strong neutralizing and binding antibody […]

The post Phase I Clinical Study For Covaxin Shows Robust Immune Response : Bharat Biotech appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/12/covaxin-phase-i-trial-report-shows-strong-immune-response/

Like
Like Love Haha Wow Sad Angry